AGNOGENIC MYELOID METAPLASIA

Clinical trials for AGNOGENIC MYELOID METAPLASIA explained in plain language.

Never miss a new study

Get alerted when new AGNOGENIC MYELOID METAPLASIA trials appear

Sign up with your email to follow new studies for AGNOGENIC MYELOID METAPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Experimental pill tested against seven rare blood diseases

Disease control Completed

This study tested whether the drug dasatinib could help control several rare blood disorders including leukemia, myelofibrosis, and mastocytosis. Participants took dasatinib pills daily for as long as it helped control their disease. Researchers monitored blood counts and bone ma…

Matched conditions: AGNOGENIC MYELOID METAPLASIA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

AGNOGENIC MYELOID METAPLASIA

Get alerted when new AGNOGENIC MYELOID METAPLASIA trials appear

Experimental pill tested against seven rare blood diseases